{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:24:46Z","timestamp":1793330686191,"version":"4.5.0"},"reference-count":134,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.metabol.2013.08.016","type":"journal-article","created":{"date-parts":[[2013,10,2]],"date-time":"2013-10-02T17:22:05Z","timestamp":1380734525000},"page":"20-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":141,"title":["Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease"],"prefix":"10.1016","volume":"63","author":[{"given":"Andreas","family":"Tomaschitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eberhard","family":"Ritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burkert","family":"Pieske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jutta","family":"Rus-Machan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Kienreich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Verheyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Gaksch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Gr\u00fcbler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Fahrleitner-Pammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Mrak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann","family":"Toplak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Kraigher-Krainer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winfried","family":"M\u00e4rz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Pilz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2013.08.016_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2012.05.007","volume":"223","author":"Perk","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2013.08.016_bb0010","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/cvr\/cvs092","article-title":"Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease","volume":"94","author":"Tomaschitz","year":"2012","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.metabol.2013.08.016_bb0015","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/MED.0b013e328360c200","article-title":"Evolving research in nongenomic actions of aldosterone","volume":"20","author":"Williams","year":"2013","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.metabol.2013.08.016_bb0020","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1161\/01.CIR.92.2.175","article-title":"Prerequisite for cardiac aldosterone action. Mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase in the human heart","volume":"92","author":"Lombes","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2013.08.016_bb0025","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.metabol.2013.08.016_bb0030","doi-asserted-by":"crossref","first-page":"I164","DOI":"10.1161\/01.HYP.23.1_Suppl.I164","article-title":"Myocardial scintigraphic characteristics in patients with primary aldosteronism","volume":"23","author":"Abe","year":"1994","journal-title":"Hypertension"},{"key":"10.1016\/j.metabol.2013.08.016_bb0035","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1161\/01.HYP.27.5.1039","article-title":"Changes in left ventricular anatomy and function in hypertension and primary aldosteronism","volume":"27","author":"Rossi","year":"1996","journal-title":"Hypertension"},{"key":"10.1016\/j.metabol.2013.08.016_bb0040","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1161\/01.HYP.29.3.723","article-title":"Left ventricular hypertrophy precedes other target-organ damage in primary aldosteronism","volume":"29","author":"Shigematsu","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.metabol.2013.08.016_bb0045","first-page":"147","article-title":"Arterial hypertension and cardiovascular disease \u2014 absolute aldosterone excess is the tip of the iceberg","volume":"35","author":"Tomaschitz","year":"2011","journal-title":"J Lab Med"},{"key":"10.1016\/j.metabol.2013.08.016_bb0050","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1055\/s-0031-1287791","article-title":"Relationship between plasma aldosterone concentration and soluble cellular adhesion molecules in patients referred to coronary angiography","volume":"119","author":"Tomaschitz","year":"2011","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.metabol.2013.08.016_bb0055","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1161\/01.CIR.82.5.1730","article-title":"Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group","volume":"82","author":"Swedberg","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2013.08.016_bb0060","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/eurheartj\/ehq019","article-title":"Plasma aldosterone levels are associated with increased cardiovascular mortality: the Ludwigshafen Risk and Cardiovascular Health (LURIC) study","volume":"31","author":"Tomaschitz","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.metabol.2013.08.016_bb0065","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1053\/j.ajkd.2010.10.047","article-title":"Association of plasma aldosterone with cardiovascular mortality in patients with low estimated GFR: the Ludwigshafen Risk and Cardiovascular Health (LURIC) Study","volume":"57","author":"Tomaschitz","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.metabol.2013.08.016_bb0070","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/eurheartj\/ehr176","article-title":"Aldosterone, mortality, and acute ischaemic events in coronary artery disease patients outside the setting of acute myocardial infarction or heart failure","volume":"33","author":"Ivanes","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.metabol.2013.08.016_bb0075","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/eurheartj\/ehs361","article-title":"Aldosterone and cortisol affect the risk of sudden cardiac death in haemodialysis patients","volume":"34","author":"Drechsler","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.metabol.2013.08.016_bb0080","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.exger.2013.01.004","article-title":"Circulating aldosterone and mortality in female nursing home residents","volume":"48","author":"Tomaschitz","year":"2013","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.metabol.2013.08.016_bb0085","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1055\/s-0030-1248326","article-title":"Aldosterone to renin ratio\u2014a reliable screening tool for primary aldosteronism?","volume":"42","author":"Tomaschitz","year":"2010","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.metabol.2013.08.016_bb0090","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/HJH.0b013e32835b71d6","article-title":"Determinants of blood pressure reduction by eplerenone in uncontrolled hypertension","volume":"31","author":"Jansen","year":"2013","journal-title":"J Hypertens"},{"key":"10.1016\/j.metabol.2013.08.016_bb0095","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/cvr\/cvr014","article-title":"Parathyroid hormone is a DPP-IV inhibitor and increases SDF-1-driven homing of CXCR4(+) stem cells into the ischaemic heart","volume":"90","author":"Huber","year":"2011","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.metabol.2013.08.016_bb0100","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00774-004-0512-4","article-title":"Primary hyperparathyroidism in elderly patients with hip fracture","volume":"22","author":"Di Monaco","year":"2004","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.metabol.2013.08.016_bb0105","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1161\/CIRCULATIONAHA.111.081307","article-title":"Coronary microvascular dysfunction induced by primary hyperparathyroidism is restored after parathyroidectomy","volume":"126","author":"Osto","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2013.08.016_bb0110","doi-asserted-by":"crossref","first-page":"e20481","DOI":"10.1371\/journal.pone.0020481","article-title":"Primary hyperparathyroidism influences the expression of inflammatory and metabolic genes in adipose tissue","volume":"6","author":"Christensen","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2013.08.016_bb0115","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3109\/00365513.2011.634432","article-title":"Factors influencing insulin sensitivity in patients with mild primary hyperparathyroidism before and after parathyroidectomy","volume":"72","author":"Almqvist","year":"2012","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.metabol.2013.08.016_bb0120","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1210\/jc.2011-2107","article-title":"Aortic valve calcification in mild primary hyperparathyroidism","volume":"97","author":"Iwata","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2013.08.016_bb0125","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.atherosclerosis.2011.05.010","article-title":"Large-artery stiffness: a reversible marker of cardiovascular risk in primary hyperparathyroidism","volume":"218","author":"Schillaci","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2013.08.016_bb0130","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3109\/00365513.2010.543694","article-title":"Increased markers of inflammation and endothelial dysfunction in patients with mild primary hyperparathyroidism","volume":"71","author":"Almqvist","year":"2011","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.metabol.2013.08.016_bb0135","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.surg.2009.09.024","article-title":"Parathyroidectomy decreases systolic and diastolic blood pressure in hypertensive patients with primary hyperparathyroidism","volume":"146","author":"Heyliger","year":"2009","journal-title":"Surgery"},{"key":"10.1016\/j.metabol.2013.08.016_bb0140","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1210\/jc.2008-1760","article-title":"Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop","volume":"94","author":"Silverberg","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 2","key":"10.1016\/j.metabol.2013.08.016_bb0145","first-page":"S111","article-title":"Longitudinal studies of mild primary hyperparathyroidism","volume":"6","author":"Ljunghall","year":"1991","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.metabol.2013.08.016_bb0150","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1530\/eje.0.1510167","article-title":"Serum parathyroid hormone level is associated with body mass index. The 5th Tromso study","volume":"151","author":"Kamycheva","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.metabol.2013.08.016_bb0155","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1067\/msy.2000.110240","article-title":"Left ventricular systolic and diastolic function and exercise testing in primary hyperparathyroidism\u2014effects of parathyroidectomy","volume":"128","author":"Nilsson","year":"2000","journal-title":"Surgery"},{"key":"10.1016\/j.metabol.2013.08.016_bb0160","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1089\/met.2012.0056","article-title":"Parathyroid hormone is associated with biomarkers of insulin resistance and inflammation, independent of vitamin D status, in obese adolescents","volume":"10","author":"Alemzadeh","year":"2012","journal-title":"Metab Syndr Relat Disord"},{"key":"10.1016\/j.metabol.2013.08.016_bb0165","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1097\/00004872-199715110-00011","article-title":"Relationship between serum parathyroid hormone levels in the elderly and 24h ambulatory blood pressures","volume":"15","author":"Morfis","year":"1997","journal-title":"J Hypertens"},{"key":"10.1016\/j.metabol.2013.08.016_bb0170","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1093\/eurheartj\/ehq109","article-title":"Parathyroid hormone level is associated with mortality and cardiovascular events in patients undergoing coronary angiography","volume":"31","author":"Pilz","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.metabol.2013.08.016_bb0175","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1161\/CIRCULATIONAHA.108.808733","article-title":"Plasma parathyroid hormone and the risk of cardiovascular mortality in the community","volume":"119","author":"Hagstrom","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2013.08.016_bb0180","doi-asserted-by":"crossref","first-page":"E638","DOI":"10.1210\/jc.2012-4007","article-title":"Serum parathyroid hormone in relation to all-cause and cardiovascular mortality: the Hoorn study","volume":"98","author":"van Ballegooijen","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2013.08.016_bb0185","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1517\/14656566.2013.777041","article-title":"Cinacalcet hydrochloride for the treatment of hyperparathyroidism","volume":"14","author":"Verheyen","year":"2013","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.metabol.2013.08.016_bb0190","first-page":"9","article-title":"The renin\u2013angiotensin aldosterone system: pathophysiological role and pharmacologic inhibition","volume":"13","author":"Atlas","year":"2007","journal-title":"J Manag Care Pharm"},{"key":"10.1016\/j.metabol.2013.08.016_bb0195","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1681\/ASN.2010121251","article-title":"Cross talk between the renin\u2013angiotensin\u2013aldosterone system and vitamin D-FGF-23-klotho in chronic kidney disease","volume":"22","author":"de Borst","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.metabol.2013.08.016_bb0200","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.metabol.2011.09.007","article-title":"The relationship between vitamin D and the renin\u2013angiotensin system in the pathophysiology of hypertension, kidney disease, and diabetes","volume":"61","author":"Vaidya","year":"2012","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2013.08.016_bb0205","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1172\/JCI0215219","article-title":"1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin\u2013angiotensin system","volume":"110","author":"Li","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2013.08.016_bb0210","doi-asserted-by":"crossref","first-page":"R255","DOI":"10.1152\/ajpregu.00517.2002","article-title":"Effect of ANG II type I receptor antagonist and ACE inhibitor on vitamin D receptor-null mice","volume":"285","author":"Kong","year":"2003","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.metabol.2013.08.016_bb0215","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/36285","article-title":"Mutation of the mouse klotho gene leads to a syndrome resembling ageing","volume":"390","author":"Kuro-o","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2013.08.016_bb0220","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1093\/eurheartj\/ehr150","article-title":"Associations of plasma renin with 10-year cardiovascular mortality, sudden cardiac death, and death due to heart failure","volume":"32","author":"Tomaschitz","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.metabol.2013.08.016_bb0225","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1161\/HYPERTENSIONAHA.111.00659","article-title":"Effect of vitamin D supplementation on blood pressure in blacks","volume":"61","author":"Forman","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.metabol.2013.08.016_bb0230","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1210\/jc.2012-1156","article-title":"Vitamin D3 therapy corrects the tissue sensitivity to angiotensin ii akin to the action of a converting enzyme inhibitor in obese hypertensives: an interventional study","volume":"97","author":"Vaidya","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2013.08.016_bb0235","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.cca.2010.05.037","article-title":"Independent association between 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D and the renin\u2013angiotensin system: the Ludwigshafen Risk and Cardiovascular Health (LURIC) study","volume":"411","author":"Tomaschitz","year":"2010","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.metabol.2013.08.016_bb0240","first-page":"1553","article-title":"Vitamin D-mediated regulation of CYP21A2 transcription \u2014 a novel mechanism for vitamin D action","volume":"2012","author":"Lundqvist","year":"1820","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.metabol.2013.08.016_bb0245","first-page":"1056","article-title":"1alpha,25-Dihydroxyvitamin D3 affects hormone production and expression of steroidogenic enzymes in human adrenocortical NCI-H295R cells","volume":"2010","author":"Lundqvist","year":"1801","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.metabol.2013.08.016_bb0250","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jsbmb.2006.12.098","article-title":"Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse","volume":"103","author":"Simpson","year":"2007","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.metabol.2013.08.016_bb0255","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.cca.2006.09.025","article-title":"Cholecalciferol treatment changes urinary sodium\u2013potassium ratio and plasma aldosterone of spontaneously hypertensive rats","volume":"376","author":"Santos Rde","year":"2007","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.metabol.2013.08.016_bb0260","article-title":"Cholecalciferol administration blunts the systemic renin\u2013angiotensin system in essential hypertensives with hypovitaminosis D","author":"Carrara","year":"2013","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/j.metabol.2013.08.016_bb0265","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1365-2265.2011.03991.x","article-title":"The Fok1 vitamin D receptor gene polymorphism is associated with plasma renin activity in Caucasians","volume":"74","author":"Vaidya","year":"2011","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.metabol.2013.08.016_bb0270","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1177\/1470320310391922","article-title":"25-Hydroxyvitamin D is associated with plasma renin activity and the pressor response to dietary sodium intake in Caucasians","volume":"12","author":"Vaidya","year":"2011","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/j.metabol.2013.08.016_bb0275","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1126\/science.1112766","article-title":"Suppression of aging in mice by the hormone Klotho","volume":"309","author":"Kurosu","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.metabol.2013.08.016_bb0280","doi-asserted-by":"crossref","first-page":"F1171","DOI":"10.1152\/ajprenal.00233.2010","article-title":"Hyperaldosteronism in Klotho-deficient mice","volume":"299","author":"Fischer","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.metabol.2013.08.016_bb0285","first-page":"812","article-title":"Spironolactone ameliorates PIT1-dependent vascular osteoinduction in klotho-hypomorphic mice","volume":"123","author":"Voelkl","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2013.08.016_bb0290","doi-asserted-by":"crossref","first-page":"F745","DOI":"10.1152\/ajprenal.00037.2011","article-title":"Downregulation of Klotho expression by dehydration","volume":"301","author":"Tang","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.metabol.2013.08.016_bb0295","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/mc.20710","article-title":"Aldosterone induces oxidative stress, oxidative DNA damage and NF-kappaB-activation in kidney tubule cells","volume":"50","author":"Queisser","year":"2011","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.metabol.2013.08.016_bb0300","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/ndt\/gft041","article-title":"Vascular calcification\u2014is aldosterone a culprit?","volume":"28","author":"Lang","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.metabol.2013.08.016_bb0305","doi-asserted-by":"crossref","first-page":"4152","DOI":"10.1210\/jc.2008-0564","article-title":"Type I membrane klotho expression is decreased and inversely correlated to serum calcium in primary hyperparathyroidism","volume":"93","author":"Bjorklund","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2013.08.016_bb0310","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000343403","article-title":"Analysis of alpha-klotho, fibroblast growth factor-, vitamin-D and calcium-sensing receptor in 70 patients with secondary hyperparathyroidism","volume":"37","author":"Latus","year":"2013","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.metabol.2013.08.016_bb0315","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1111\/j.1532-5415.2011.03558.x","article-title":"Plasma klotho and cardiovascular disease in adults","volume":"59","author":"Semba","year":"2011","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.metabol.2013.08.016_bb0320","doi-asserted-by":"crossref","first-page":"5544","DOI":"10.1210\/endo.137.12.8940382","article-title":"Possible role for mitochondrial calcium in angiotensin II- and potassium-stimulated steroidogenesis in bovine adrenal glomerulosa cells","volume":"137","author":"Brandenburger","year":"1996","journal-title":"Endocrinology"},{"key":"10.1016\/j.metabol.2013.08.016_bb0325","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1152\/physrev.00030.2003","article-title":"Control of aldosterone secretion: a model for convergence in cellular signaling pathways","volume":"84","author":"Spat","year":"2004","journal-title":"Physiol Rev"},{"key":"10.1016\/j.metabol.2013.08.016_bb0330","doi-asserted-by":"crossref","first-page":"25971","DOI":"10.1074\/jbc.271.42.25971","article-title":"Calcium stimulates intramitochondrial cholesterol transfer in bovine adrenal glomerulosa cells","volume":"271","author":"Cherradi","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2013.08.016_bb0335","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1210\/endo-129-1-489","article-title":"Parathyroid hormone modulates angiotensin II-induced aldosterone secretion from the adrenal glomerulosa cell","volume":"129","author":"Isales","year":"1991","journal-title":"Endocrinology"},{"key":"10.1016\/j.metabol.2013.08.016_bb0340","first-page":"309","article-title":"Enhancement of the stimulatory effect of calcium on aldosterone secretion by parathyroid hormone","volume":"20","author":"Olgaard","year":"1994","journal-title":"Miner Electrolyte Metab"},{"key":"10.1016\/j.metabol.2013.08.016_bb0345","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1210\/endo.133.2.8393771","article-title":"Parathyroid hormone (PTH)\/PTH-related peptide receptor messenger ribonucleic acids are widely distributed in rat tissues","volume":"133","author":"Urena","year":"1993","journal-title":"Endocrinology"},{"key":"10.1016\/j.metabol.2013.08.016_bb0350","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1677\/joe.0.1120431","article-title":"Response of adrenal cells to parathyroid hormone stimulation","volume":"112","author":"Rosenberg","year":"1987","journal-title":"J Endocrinol"},{"key":"10.1016\/j.metabol.2013.08.016_bb0355","first-page":"360","article-title":"Chronic continuous PTH infusion results in hypertension in normal subjects","volume":"2","author":"Hulter","year":"1986","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.metabol.2013.08.016_bb0360","doi-asserted-by":"crossref","first-page":"E209","DOI":"10.1152\/ajpendo.2001.280.2.E209","article-title":"PTH and PTH-related peptide enhance steroid secretion from human adrenocortical cells","volume":"280","author":"Mazzocchi","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2013.08.016_bb0365","doi-asserted-by":"crossref","first-page":"S192","DOI":"10.1097\/00004872-198900076-00092","article-title":"Aldosterone and pressor responses to angiotensin II in primary hyperparathyroidism","volume":"7","author":"Fallo","year":"1989","journal-title":"J Hypertens Suppl"},{"key":"10.1016\/j.metabol.2013.08.016_bb0370","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1161\/HYPERTENSIONAHA.111.173948","article-title":"Primary hyperparathyroidism with concurrent primary aldosteronism","volume":"58","author":"Maniero","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.metabol.2013.08.016_bb0375","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1158\/1055-9965.EPI-07-2924","article-title":"Differential expression of parathyroid hormone-related protein in adrenocortical tumors: autocrine\/paracrine effects on the growth and signaling pathways in H295R cells","volume":"17","author":"Rizk-Rabin","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.metabol.2013.08.016_bb0380","first-page":"77","article-title":"Hypertension and primary hyperparathyroidism: the role of adrenergic and renin\u2013angiotensin\u2013aldosterone systems","volume":"21","author":"Gennari","year":"1995","journal-title":"Miner Electrolyte Metab"},{"key":"10.1016\/j.metabol.2013.08.016_bb0385","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1530\/eje.0.1380543","article-title":"The effect of surgical treatment on secondary hyperaldosteronism and relative hyperinsulinemia in primary hyperparathyroidism","volume":"138","author":"Kovacs","year":"1998","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.metabol.2013.08.016_bb0390","doi-asserted-by":"crossref","first-page":"776","DOI":"10.7326\/0003-4819-150-11-200906020-00005","article-title":"Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension","volume":"150","author":"Sowers","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.metabol.2013.08.016_bb0395","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1210\/jc.2005-1733","article-title":"Prevalence and characteristics of the metabolic syndrome in primary aldosteronism","volume":"91","author":"Fallo","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2013.08.016_bb0400","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1161\/HYPERTENSIONAHA.111.180521","article-title":"Plasma aldosterone levels and development of insulin resistance: prospective study in a general population","volume":"58","author":"Kumagai","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.metabol.2013.08.016_bb0405","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1161\/HYPERTENSIONAHA.108.122002","article-title":"Fasting plasma glucose and serum lipids in patients with primary aldosteronism: a controlled cross-sectional study","volume":"53","author":"Matrozova","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.metabol.2013.08.016_bb0410","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1210\/jc.2011-0238","article-title":"Mild primary hyperparathyroidism: vitamin D deficiency and cardiovascular risk markers","volume":"96","author":"Farahnak","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2013.08.016_bb0415","doi-asserted-by":"crossref","first-page":"408295","DOI":"10.1155\/2012\/408295","article-title":"Arterial hypertension, metabolic syndrome and subclinical cardiovascular organ damage in patients with asymptomatic primary hyperparathyroidism before and after parathyroidectomy: preliminary results","volume":"2012","author":"Luigi","year":"2012","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.metabol.2013.08.016_bb0420","doi-asserted-by":"crossref","first-page":"974647","DOI":"10.1155\/2011\/974647","article-title":"Hypertension secondary to PHPT: cause or coincidence?","volume":"2011","author":"Schiffl","year":"2011","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.metabol.2013.08.016_bb0425","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/BF02563790","article-title":"Adrenal responses to subtotal parathyroidectomy for primary hyperparathyroidism","volume":"41","author":"Pacifici","year":"1987","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.metabol.2013.08.016_bb0430","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/hr.2010.251","article-title":"Hyperparathyroidism, arterial hypertension and aortic stiffness: a possible bidirectional link between the adrenal cortex and the parathyroid glands that causes vascular damage?","volume":"34","author":"Rossi","year":"2011","journal-title":"Hypertens Res"},{"key":"10.1016\/j.metabol.2013.08.016_bb0435","doi-asserted-by":"crossref","first-page":"584","DOI":"10.4158\/EP10321.OR","article-title":"Effects of successful parathyroidectomy on metabolic cardiovascular risk factors in patients with severe primary hyperparathyroidism","volume":"17","author":"Ishay","year":"2011","journal-title":"Endocr Pract"},{"key":"10.1016\/j.metabol.2013.08.016_bb0440","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.surg.2009.09.041","article-title":"Serum aldosterone is correlated positively to parathyroid hormone (PTH) levels in patients with primary hyperparathyroidism","volume":"146","author":"Brunaud","year":"2009","journal-title":"Surgery"},{"key":"10.1016\/j.metabol.2013.08.016_bb0445","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/bmj.327.7414.530","article-title":"Cohort study on effects of parathyroid surgery on multiple outcomes in primary hyperparathyroidism","volume":"327","author":"Vestergaard","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.metabol.2013.08.016_bb0450","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0026-0495(99)90075-6","article-title":"Renin\u2013angiotensin\u2013aldosterone system in primary hyperparathyroidism before and after surgery","volume":"48","author":"Bernini","year":"1999","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2013.08.016_bb0455","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1472-6823-12-19","article-title":"Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: a randomized, double-blind, placebo-controlled trial","volume":"12","author":"Tomaschitz","year":"2012","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.metabol.2013.08.016_bb0460","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s10157-011-0534-x","article-title":"Influence of renin\u2013angiotensin system on serum parathyroid hormone levels in uremic patients","volume":"16","author":"Koiwa","year":"2012","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.metabol.2013.08.016_bb0465","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s10557-012-6378-0","article-title":"Parathyroid hormone, a crucial mediator of pathologic cardiac remodeling in aldosteronism","volume":"27","author":"Rutledge","year":"2013","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.metabol.2013.08.016_bb0470","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000441-200507000-00001","article-title":"Bone loss in rats with aldosteronism","volume":"330","author":"Runyan","year":"2005","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.metabol.2013.08.016_bb0475","doi-asserted-by":"crossref","first-page":"H2023","DOI":"10.1152\/ajpheart.00477.2004","article-title":"Loss of bone minerals and strength in rats with aldosteronism","volume":"287","author":"Chhokar","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.metabol.2013.08.016_bb0480","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jacc.2005.03.055","article-title":"Diuretics and bone loss in rats with aldosteronism","volume":"46","author":"Law","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.metabol.2013.08.016_bb0485","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s00774-011-0275-7","article-title":"Acute-onset hypomagnesemia-induced hypocalcemia caused by the refractoriness of bones and renal tubules to parathyroid hormone","volume":"29","author":"Yamamoto","year":"2011","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.metabol.2013.08.016_bb0490","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1161\/01.CIR.0000155621.10213.06","article-title":"Hyperparathyroidism and the calcium paradox of aldosteronism","volume":"111","author":"Chhokar","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2013.08.016_bb0495","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jacc.2008.03.039","article-title":"Fracture risk in men with congestive heart failure risk reduction with spironolactone","volume":"52","author":"Carbone","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.metabol.2013.08.016_bb0500","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/FJC.0b013e3181cf0090","article-title":"Uncoupling the coupled calcium and zinc dyshomeostasis in cardiac myocytes and mitochondria seen in aldosteronism","volume":"55","author":"Kamalov","year":"2010","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.metabol.2013.08.016_bb0505","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/00000441-200601000-00009","article-title":"Secondary hyperparathyroidism in patients with untreated and treated congestive heart failure","volume":"331","author":"Khouzam","year":"2006","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.metabol.2013.08.016_bb0510","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/MAJ.0b013e318167b0bd","article-title":"Hypovitaminosis D in African Americans residing in Memphis, Tennessee with and without heart failure","volume":"335","author":"Alsafwah","year":"2008","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.metabol.2013.08.016_bb0515","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/FJC.0b013e31821cd83c","article-title":"Mitochondriocentric pathway to cardiomyocyte necrosis in aldosteronism: cardioprotective responses to carvedilol and nebivolol","volume":"58","author":"Cheema","year":"2011","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.metabol.2013.08.016_bb0520","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1042\/BST0340232","article-title":"Calcium, mitochondria and reperfusion injury: a pore way to die","volume":"34","author":"Halestrap","year":"2006","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.metabol.2013.08.016_bb0525","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1159\/000184942","article-title":"Renal handling of calcium and phosphate during mineralocorticoid administration in normal subjects","volume":"48","author":"Cappuccio","year":"1988","journal-title":"Nephron"},{"key":"10.1016\/j.metabol.2013.08.016_bb0530","first-page":"F879","article-title":"Hypercalciuria of mineralocorticoid escape: clearance and micropuncture studies in the rat","volume":"251","author":"Gehr","year":"1986","journal-title":"Am J Physiol"},{"key":"10.1016\/j.metabol.2013.08.016_bb0535","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00000441-197607000-00004","article-title":"Disposition and regulation of body potassium: an overview","volume":"272","author":"Suki","year":"1976","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.metabol.2013.08.016_bb0540","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000179814","article-title":"Studies of the acute effects of aldosterone and cortisol on the interrelationship between renal sodium, calcium and magnesium excretion in normal man","volume":"7","author":"Lemann","year":"1970","journal-title":"Nephron"},{"key":"10.1016\/j.metabol.2013.08.016_bb0545","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.pharmthera.2005.10.010","article-title":"Rapid actions of aldosterone in vascular health and disease\u2014friend or foe?","volume":"111","author":"Skott","year":"2006","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.metabol.2013.08.016_bb0550","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1161\/ATVBAHA.111.242719","article-title":"Biphasic time course of the changes in aldosterone biosynthesis under high-salt conditions in Dahl salt-sensitive rats","volume":"32","author":"Morizane","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2013.08.016_bb0555","first-page":"R423","article-title":"NaCl ingestion ameliorates plasma indexes of calcium deficiency","volume":"273","author":"Tordoff","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1016\/j.metabol.2013.08.016_bb0560","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1681\/ASN.2004070523","article-title":"Epithelial Ca2+ and Mg2+ channels in health and disease","volume":"16","author":"Hoenderop","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.metabol.2013.08.016_bb0565","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1161\/HYPERTENSIONAHA.111.172890","article-title":"Hypercalcemia reduces plasma renin via parathyroid hormone, renal interstitial calcium, and the calcium-sensing receptor","volume":"58","author":"Atchison","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.metabol.2013.08.016_bb0570","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000166496","article-title":"Urinary calcium excretion at extremes of sodium intake in normal man","volume":"1","author":"McCarron DA","year":"1981","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.metabol.2013.08.016_bb0575","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0895-7061(97)00366-X","article-title":"Acute effects of intravenous sodium chloride load on calcium metabolism and on parathyroid function in patients with primary aldosteronism compared with subjects with essential hypertension","volume":"11","author":"Rossi","year":"1998","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.metabol.2013.08.016_bb0580","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients","volume":"48","author":"Rossi","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.metabol.2013.08.016_bb0585","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1016\/j.jacc.2010.01.032","article-title":"Aldosterone\/renin ratio determines peripheral and central blood pressure values over a broad range","volume":"55","author":"Tomaschitz","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.metabol.2013.08.016_bb0590","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1161\/01.HYP.0000023182.68420.EB","article-title":"Excess aldosterone is associated with alterations of myocardial texture in primary aldosteronism","volume":"40","author":"Rossi","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.metabol.2013.08.016_bb0595","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1001\/jama.295.22.2638","article-title":"Long-term renal outcomes in patients with primary aldosteronism","volume":"295","author":"Sechi","year":"2006","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.metabol.2013.08.016_bb0600","doi-asserted-by":"crossref","first-page":"649","DOI":"10.7326\/0003-4819-105-5-649","article-title":"Calcium-regulating hormones in essential hypertension. Relation to plasma renin activity and sodium metabolism","volume":"105","author":"Resnick","year":"1986","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.metabol.2013.08.016_bb0605","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0002-9343(85)90328-6","article-title":"Calcium metabolism and parathyroid function in primary aldosteronism","volume":"78","author":"Resnick","year":"1985","journal-title":"Am J Med"},{"key":"10.1016\/j.metabol.2013.08.016_bb0610","first-page":"17","article-title":"Renal calculi in primary hyperaldosteronism","volume":"41","author":"Kabadi","year":"1995","journal-title":"J Postgrad Med"},{"key":"10.1016\/j.metabol.2013.08.016_bb0615","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/0895-7061(95)00182-O","article-title":"Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas","volume":"8","author":"Rossi","year":"1995","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.metabol.2013.08.016_bb0620","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00223-010-9409-5","article-title":"Aldosterone and parathyroid hormone: a complex and clinically relevant relationship","volume":"87","author":"Pilz","year":"2010","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.metabol.2013.08.016_bb0625","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1472-6823-9-11","article-title":"Graz Endocrine Causes of Hypertension (GECOH) study: a diagnostic accuracy study of aldosterone to active renin ratio in screening for primary aldosteronism","volume":"9","author":"Pilz","year":"2009","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.metabol.2013.08.016_bb0630","doi-asserted-by":"crossref","first-page":"E75","DOI":"10.1210\/jc.2011-2183","article-title":"Hyperparathyroidism in patients with primary aldosteronism: cross-sectional and interventional data from the GECOH study","volume":"97","author":"Pilz","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2013.08.016_bb0635","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/HJH.0b013e32834f0451","article-title":"Mild hyperparathyroidism: a novel surgically correctable feature of primary aldosteronism","volume":"30","author":"Maniero","year":"2012","journal-title":"J Hypertens"},{"key":"10.1016\/j.metabol.2013.08.016_bb0640","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1161\/HYPERTENSIONAHA.112.195891","article-title":"Hyperparathyroidism can be useful in the identification of primary aldosteronism due to aldosterone-producing adenoma","volume":"60","author":"Rossi","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.metabol.2013.08.016_bb0645","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1359\/jbmr.2001.16.8.1496","article-title":"Colocalization of glucocorticoid and mineralocorticoid receptors in human bone","volume":"16","author":"Beavan","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.metabol.2013.08.016_bb0650","doi-asserted-by":"crossref","first-page":"H286","DOI":"10.1152\/ajpheart.00535.2005","article-title":"Calcium paradox of aldosteronism and the role of the parathyroid glands","volume":"290","author":"Vidal","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.metabol.2013.08.016_bb0655","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1002\/jbmr.333","article-title":"Identification of homogeneous genetic architecture of multiple genetically correlated traits by block clustering of genome-wide associations","volume":"26","author":"Gupta","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.metabol.2013.08.016_bb0660","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1002\/jbmr.1660","article-title":"Bone involvement in aldosteronism","volume":"27","author":"Salcuni","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.metabol.2013.08.016_bb0665","doi-asserted-by":"crossref","DOI":"10.1007\/s00198-013-2399-1","article-title":"Bone health and aldosterone excess","author":"Ceccoli","year":"2013","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.metabol.2013.08.016_bb0670","doi-asserted-by":"crossref","first-page":"R956","DOI":"10.1152\/ajpregu.00111.2007","article-title":"A PTH\/PTHrP receptor antagonist blocks the hypercalcemic response to estradiol-17beta","volume":"293","author":"Fuentes","year":"2007","journal-title":"Am J Physiol Regul Integr Comp Physiol"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049513002783?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049513002783?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:02:31Z","timestamp":1758427351000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049513002783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":134,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0026049513002783"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2013.08.016","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2013.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}